Home
E-submission
Sitemap
Contact us
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE & TOPICS
Article Category
Editorial
Review
Original article
Case report
Images of the issue
Letters to the editor
Others
Browse all articles >
TOPICS
IBD
Microbiota
Tumor
Endoscopy
Functional disorder
Infection
Miscellaneous
Browse all articles >
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Hot topic
Funded articles
Search
Author index
EDITORIAL POLICY
Research & publication ethics
Peer review policy
Copyright & license
Others
- Data sharing policy
- Archiving policy
- Preprint policy
- Advertising policy
- CrossMark policy
FOR CONTRIBUTORS
FOR AUTHORS
Instructions to authors
Review flow
Article processing charge
Author’s checklist
Copyright transfer agreement
E-submission
FOR REVIEWERS
Instructions to reviewers
How to become a reviewer?
FOR READERS
Open access
Subscription information
TOC alerts
How to cite this journal?
Permission request
Search
Intest Res Search
CLOSE
Search
Page Path
HOME
Search
Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab
Hisashi Shiga, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Rintaro Moroi, Yoichi Kakuta, Yoshitaka Kinouchi, Atsushi Masamune
Received December 27, 2023 Accepted February 19, 2024
DOI:
https://doi.org/10.5217/ir.2023.00203
[Epub ahead of print]
Full text
PubReader
ePub
PDF
IBD
Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with
NUDT15
heterozygosity
Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Yoichi Kakuta, Hidezumi Kikuchi, Shogo Kawaguchi, Keisuke Hasui, Tetsuya Tatsuta, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda
Intest Res.
2022;20(1):90-100.
Published online January 22, 2021
DOI:
https://doi.org/10.5217/ir.2020.00133
Web of Science 8
Crossref 7
Full text
PubReader
ePub
PDF
Supplementary Material
Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
Rintaro Moroi, Katsuya Endo, Katsutoshi Yamamoto, Takeo Naito, Motoyuki Onodera, Masatake Kuroha, Yoshitake Kanazawa, Tomoya Kimura, Yoichi Kakuta, Atsushi Masamune, Yoshitaka Kinouchi, Tooru Shimosegawa
Intest Res.
2019;17(1):94-106.
Published online December 3, 2018
DOI:
https://doi.org/10.5217/ir.2018.00048
Web of Science 8
Crossref 8
Full text
PubReader
ePub
PDF
Supplementary Material
NUDT15
,
FTO
, and
RUNX1
genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
Toshiyuki Sato, Tetsuya Takagawa, Yoichi Kakuta, Akihiro Nishio, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama, Yuko Kita, Takako Miyazaki, Masaki Iimuro, Nobuyuki Hida, Kazutoshi Hori, Hiroki Ikeuchi, Shiro Nakamura
Intest Res.
2017;15(3):328-337.
Published online June 12, 2017
DOI:
https://doi.org/10.5217/ir.2017.15.3.328
Web of Science 34
Crossref 31
Full text
PubReader
ePub
PDF
1
Journal Impact Factor 4.9
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE & TOPICS
Article Category
Editorial
Review
Original article
Case report
Images of the issue
Letters to the editor
Others
Browse all articles >
TOPICS
IBD
Microbiota
Tumor
Endoscopy
Functional disorder
Infection
Miscellaneous
Browse all articles >
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Hot topic
Funded articles
Search
Author index
EDITORIAL POLICY
Research & publication ethics
Peer review policy
Copyright & license
Others
- Data sharing policy
- Archiving policy
- Preprint policy
- Advertising policy
- CrossMark policy
AUTHOR INFORMATION
FOR AUTHORS
Instructions to authors
Review flow
Article processing charge
Author’s checklist
Copyright transfer agreement
E-submission
FOR REVIEWERS
Instructions to reviewers
How to become a reviewer?